Detailed answers about ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD, including incorporation, status, business activity, and accounts information.
When was ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD founded?
ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD was officially incorporated on 21 October 2014 and is registered under company number 09272823. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD?
ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD do?
ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD operates in the following sectors: 72110 - Research and experimental development on biotechnology, 74909 - Other professional, scientific and technical activities n.e.c., 82990 - Other business support service activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD's registered address?
The registered office address of ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD is ONEGA HOUSE, 112, MAIN ROAD, SIDCUP, ENGLAND, DA14 6NE. This is the official address filed with Companies House for legal and statutory correspondence.
Is ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD financially stable?
The most recent accounts for ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD were made up to 31 October 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 July 2026.